Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $8.21 million. The enterprise value is -$8.06 million.

Market Cap	8.21M
Enterprise Value	-8.06M

Important Dates

The next estimated earnings date is Monday, August 18, 2025, after market close.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

TSBX has 23.14 million shares outstanding. The number of shares has increased by 6.59% in one year.

Current Share Class	23.14M
Shares Outstanding	23.14M
Shares Change (YoY)	+6.59%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	25.05%
Float	19.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.03.

Current Ratio	3.33
Quick Ratio	2.63
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -126.71% and return on invested capital (ROIC) is -73.42%.

Return on Equity (ROE)	-126.71%
Return on Assets (ROA)	-57.78%
Return on Invested Capital (ROIC)	-73.42%
Return on Capital Employed (ROCE)	-306.78%
Revenue Per Employee	n/a
Profits Per Employee	-$3.37M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSBX has paid $33,000 in taxes.

Income Tax	33,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.60% in the last 52 weeks. The beta is 1.37, so TSBX's price volatility has been higher than the market average.

Beta (5Y)	1.37
52-Week Price Change	-83.60%
50-Day Moving Average	0.36
200-Day Moving Average	0.41
Relative Strength Index (RSI)	49.25
Average Volume (20 Days)	149,162

Short Selling Information

The latest short interest is 281,355, so 1.22% of the outstanding shares have been sold short.

Short Interest	281,355
Short Previous Month	334,611
Short % of Shares Out	1.22%
Short % of Float	1.41%
Short Ratio (days to cover)	0.60

Income Statement

Revenue	n/a
Gross Profit	-55.63M
Operating Income	-45.29M
Pretax Income	-75.09M
Net Income	-47.20M
EBITDA	-44.16M
EBIT	-45.29M
Earnings Per Share (EPS)	-$2.05

Full Income Statement

Balance Sheet

The company has $16.69 million in cash and $411,000 in debt, giving a net cash position of $16.28 million or $0.70 per share.

Cash & Cash Equivalents	16.69M
Total Debt	411,000
Net Cash	16.28M
Net Cash Per Share	$0.70
Equity (Book Value)	14.76M
Book Value Per Share	0.64
Working Capital	14.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.45 million and capital expenditures $20,000, giving a free cash flow of -$45.43 million.

Operating Cash Flow	-45.45M
Capital Expenditures	20,000
Free Cash Flow	-45.43M
FCF Per Share	-$1.96

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.59%
Shareholder Yield	-6.59%
Earnings Yield	-574.56%
FCF Yield	-552.99%

Analyst Forecast

The average price target for TSBX is $4.75, which is 1,238.03% higher than the current price. The consensus rating is "Buy".

Price Target	$4.75
Price Target Difference	1,238.03%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1